The CRISPR-powered Diagnostic SLEUTH - Summary - MDSpire

The CRISPR-powered Diagnostic SLEUTH

Novel DNA-guided system may support future RNA diagnostics and mutation detection

  • May 22, 2026

  • 2 min

Share

Objective:

To develop a modified CRISPR–Cas12a system using DNA guides for RNA detection and cutting.

Key Findings:
  • The DNA-guided Cas12a system accurately recognizes and cleaves RNA with strong sequence specificity.
  • The system can detect RNA targets at low concentrations without preamplification.
  • The assay showed complete agreement with RT-qPCR results in testing with SARS-CoV-2 clinical samples.
  • The system can distinguish single-nucleotide sequence differences, aiding mutation detection.
  • Minimal off-target effects were observed in transcriptome analysis.
Interpretation:

The study presents a new platform for RNA detection that could enhance existing CRISPR-based diagnostics.

Limitations:
  • DNA-guided complexes were less stable than conventional RNA-guided systems.
  • Intracellular RNA knockdown was modest.
Conclusion:

The findings indicate that programmable RNA targeting is achievable with DNA-guided CRISPR technology, suggesting potential for future molecular diagnostics.

Original Source(s)

The CRISPR-powered Diagnostic SLEUTH

  • May 22, 2026

Related Content

Why Pathology Needs Enterprise Imaging

Nabile Safdar and Cheryl Carey explore enterprise imaging, interoperability, and lessons from radiology's digital transformation

Autism Spectrum Disorder Linked to Distinct Urine Metabolite Pattern

Researchers proposed a new autism spectrum disorder phenotype characterized by elevated urinary microbially derived metabolites.

Tracking Ebola's Next Move

As cases continue to rise in the Democratic Republic of the Congo and Uganda, David Schwartz discusses diagnostics, surveillance, and outbreak preparedness